Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120

Zhuying Wang, Olga Pekarskaya, Meryem Bencheikh, Wei Chao, Harris A. Gelbard, Anuja Ghorpade, Jeffrey D. Rothstein, David J. Volsky

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

L-Glutamate is the major excitatory neurotransmitter in the brain. Astrocytes maintain low levels of synaptic glutamate by high-affinity uptake and defects in this function may lead to neuronal cell death by excitotoxicity. We tested the effects of HIV-1 and its envelope glycoprotein gp120 upon glutamate uptake and expression of glutamate transporters EAAT1 and EAAT2 in fetal human astrocytes in vitro. Astrocytes isolated from fetal tissues between 16 and 19 weeks of gestation expressed EAAT1 and EAAT2 RNA and proteins as detected by Northern blot analysis and immunoblotting, respectively, and the cells were capable of specific glutamate uptake. Exposure of astrocytes to HIV-1 or gp120 significantly impaired glutamate uptake by the cells, with maximum inhibition within 6 h, followed by gradual decline during 3 days of observation. HIV-1-infected cells showed a 59% reduction in Vmax for glutamate transport, indicating a reduction in the number of active transporter sites on the cell surface. Impaired glutamate transport after HIV-1 infection or gp120 exposure correlated with a 40-70% decline in steady-state levels of EAAT2 RNA and protein. EAAT1 RNA and protein levels were less affected. Treatment of astrocytes with tumor necrosis factor-α (TNF-α) decreased the expression of both EAAT1 and EAAT2, but neither HIV-1 nor gp120 were found to induce TNF-α production by astrocytes. These findings demonstrate that HIV-1 and gp120 induce transcriptional downmodulation of the EAAT2 transporter gene in human astrocytes and coordinately attenuate glutamate transport by the cells. Reduction of the ability of HIV-1-infected astrocytes to take up glutamate may contribute to the development of neurological disease.

Original languageEnglish
Pages (from-to)60-73
Number of pages14
JournalVirology
Volume312
Issue number1
DOIs
StatePublished - 20 Jul 2003

Fingerprint

Amino Acid Transport System X-AG
Astrocytes
HIV-1
Glutamic Acid
RNA
Tumor Necrosis Factor-alpha
Proteins
Immunoblotting
Northern Blotting
HIV Infections
Neurotransmitter Agents
Catalytic Domain
Glycoproteins
Fetus
Cell Death
Observation
Pregnancy

Keywords

  • Astrocytes
  • Glutamate uptake
  • HAD
  • HIV-1
  • Neuropathogenesis
  • TNF-α
  • gp120

Cite this

Wang, Z., Pekarskaya, O., Bencheikh, M., Chao, W., Gelbard, H. A., Ghorpade, A., ... Volsky, D. J. (2003). Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology, 312(1), 60-73. https://doi.org/10.1016/S0042-6822(03)00181-8
Wang, Zhuying ; Pekarskaya, Olga ; Bencheikh, Meryem ; Chao, Wei ; Gelbard, Harris A. ; Ghorpade, Anuja ; Rothstein, Jeffrey D. ; Volsky, David J. / Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. In: Virology. 2003 ; Vol. 312, No. 1. pp. 60-73.
@article{c243c43011c34e729d952b5a05ecbeaa,
title = "Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120",
abstract = "L-Glutamate is the major excitatory neurotransmitter in the brain. Astrocytes maintain low levels of synaptic glutamate by high-affinity uptake and defects in this function may lead to neuronal cell death by excitotoxicity. We tested the effects of HIV-1 and its envelope glycoprotein gp120 upon glutamate uptake and expression of glutamate transporters EAAT1 and EAAT2 in fetal human astrocytes in vitro. Astrocytes isolated from fetal tissues between 16 and 19 weeks of gestation expressed EAAT1 and EAAT2 RNA and proteins as detected by Northern blot analysis and immunoblotting, respectively, and the cells were capable of specific glutamate uptake. Exposure of astrocytes to HIV-1 or gp120 significantly impaired glutamate uptake by the cells, with maximum inhibition within 6 h, followed by gradual decline during 3 days of observation. HIV-1-infected cells showed a 59{\%} reduction in Vmax for glutamate transport, indicating a reduction in the number of active transporter sites on the cell surface. Impaired glutamate transport after HIV-1 infection or gp120 exposure correlated with a 40-70{\%} decline in steady-state levels of EAAT2 RNA and protein. EAAT1 RNA and protein levels were less affected. Treatment of astrocytes with tumor necrosis factor-α (TNF-α) decreased the expression of both EAAT1 and EAAT2, but neither HIV-1 nor gp120 were found to induce TNF-α production by astrocytes. These findings demonstrate that HIV-1 and gp120 induce transcriptional downmodulation of the EAAT2 transporter gene in human astrocytes and coordinately attenuate glutamate transport by the cells. Reduction of the ability of HIV-1-infected astrocytes to take up glutamate may contribute to the development of neurological disease.",
keywords = "Astrocytes, Glutamate uptake, HAD, HIV-1, Neuropathogenesis, TNF-α, gp120",
author = "Zhuying Wang and Olga Pekarskaya and Meryem Bencheikh and Wei Chao and Gelbard, {Harris A.} and Anuja Ghorpade and Rothstein, {Jeffrey D.} and Volsky, {David J.}",
year = "2003",
month = "7",
day = "20",
doi = "10.1016/S0042-6822(03)00181-8",
language = "English",
volume = "312",
pages = "60--73",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

Wang, Z, Pekarskaya, O, Bencheikh, M, Chao, W, Gelbard, HA, Ghorpade, A, Rothstein, JD & Volsky, DJ 2003, 'Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120', Virology, vol. 312, no. 1, pp. 60-73. https://doi.org/10.1016/S0042-6822(03)00181-8

Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. / Wang, Zhuying; Pekarskaya, Olga; Bencheikh, Meryem; Chao, Wei; Gelbard, Harris A.; Ghorpade, Anuja; Rothstein, Jeffrey D.; Volsky, David J.

In: Virology, Vol. 312, No. 1, 20.07.2003, p. 60-73.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120

AU - Wang, Zhuying

AU - Pekarskaya, Olga

AU - Bencheikh, Meryem

AU - Chao, Wei

AU - Gelbard, Harris A.

AU - Ghorpade, Anuja

AU - Rothstein, Jeffrey D.

AU - Volsky, David J.

PY - 2003/7/20

Y1 - 2003/7/20

N2 - L-Glutamate is the major excitatory neurotransmitter in the brain. Astrocytes maintain low levels of synaptic glutamate by high-affinity uptake and defects in this function may lead to neuronal cell death by excitotoxicity. We tested the effects of HIV-1 and its envelope glycoprotein gp120 upon glutamate uptake and expression of glutamate transporters EAAT1 and EAAT2 in fetal human astrocytes in vitro. Astrocytes isolated from fetal tissues between 16 and 19 weeks of gestation expressed EAAT1 and EAAT2 RNA and proteins as detected by Northern blot analysis and immunoblotting, respectively, and the cells were capable of specific glutamate uptake. Exposure of astrocytes to HIV-1 or gp120 significantly impaired glutamate uptake by the cells, with maximum inhibition within 6 h, followed by gradual decline during 3 days of observation. HIV-1-infected cells showed a 59% reduction in Vmax for glutamate transport, indicating a reduction in the number of active transporter sites on the cell surface. Impaired glutamate transport after HIV-1 infection or gp120 exposure correlated with a 40-70% decline in steady-state levels of EAAT2 RNA and protein. EAAT1 RNA and protein levels were less affected. Treatment of astrocytes with tumor necrosis factor-α (TNF-α) decreased the expression of both EAAT1 and EAAT2, but neither HIV-1 nor gp120 were found to induce TNF-α production by astrocytes. These findings demonstrate that HIV-1 and gp120 induce transcriptional downmodulation of the EAAT2 transporter gene in human astrocytes and coordinately attenuate glutamate transport by the cells. Reduction of the ability of HIV-1-infected astrocytes to take up glutamate may contribute to the development of neurological disease.

AB - L-Glutamate is the major excitatory neurotransmitter in the brain. Astrocytes maintain low levels of synaptic glutamate by high-affinity uptake and defects in this function may lead to neuronal cell death by excitotoxicity. We tested the effects of HIV-1 and its envelope glycoprotein gp120 upon glutamate uptake and expression of glutamate transporters EAAT1 and EAAT2 in fetal human astrocytes in vitro. Astrocytes isolated from fetal tissues between 16 and 19 weeks of gestation expressed EAAT1 and EAAT2 RNA and proteins as detected by Northern blot analysis and immunoblotting, respectively, and the cells were capable of specific glutamate uptake. Exposure of astrocytes to HIV-1 or gp120 significantly impaired glutamate uptake by the cells, with maximum inhibition within 6 h, followed by gradual decline during 3 days of observation. HIV-1-infected cells showed a 59% reduction in Vmax for glutamate transport, indicating a reduction in the number of active transporter sites on the cell surface. Impaired glutamate transport after HIV-1 infection or gp120 exposure correlated with a 40-70% decline in steady-state levels of EAAT2 RNA and protein. EAAT1 RNA and protein levels were less affected. Treatment of astrocytes with tumor necrosis factor-α (TNF-α) decreased the expression of both EAAT1 and EAAT2, but neither HIV-1 nor gp120 were found to induce TNF-α production by astrocytes. These findings demonstrate that HIV-1 and gp120 induce transcriptional downmodulation of the EAAT2 transporter gene in human astrocytes and coordinately attenuate glutamate transport by the cells. Reduction of the ability of HIV-1-infected astrocytes to take up glutamate may contribute to the development of neurological disease.

KW - Astrocytes

KW - Glutamate uptake

KW - HAD

KW - HIV-1

KW - Neuropathogenesis

KW - TNF-α

KW - gp120

UR - http://www.scopus.com/inward/record.url?scp=0012450945&partnerID=8YFLogxK

U2 - 10.1016/S0042-6822(03)00181-8

DO - 10.1016/S0042-6822(03)00181-8

M3 - Article

C2 - 12890621

AN - SCOPUS:0012450945

VL - 312

SP - 60

EP - 73

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -